UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California

UCSF Helen Diller Family Comprehensive Cancer Center is a clinical research site located in San Francisco, California, United States 94115.

Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.

UCSF Helen Diller Family Comprehensive Cancer Center has participated in 265 clinical trials with 46 currently active.

Therapeutic areas: Lymphoma, Neuroblastoma, Neoplasm.

Sponsors: Children's Oncology Group, New Approaches to Neuroblastoma Therapy Consortium, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Francisco

Browse all research sites in California · View every site in San Francisco

Sponsor Feasibility Report

Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCSF Helen Diller Family Comprehensive Cancer Center?

UCSF Helen Diller Family Comprehensive Cancer Center has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCSF Helen Diller Family Comprehensive Cancer Center conducted?

UCSF Helen Diller Family Comprehensive Cancer Center has 265 clinical trials on record, with 46 currently active. Their work covers Lymphoma, Neuroblastoma, Neoplasm.

Is UCSF Helen Diller Family Comprehensive Cancer Center accredited by Crixeo Clinical Trials?

UCSF Helen Diller Family Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCSF Helen Diller Family Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.